These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33796992)

  • 21. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Convergence of endobariatrics and endohepatology for evaluation and treatment of obesity and nonalcoholic fatty liver disease.
    Krishnan A; Shah-Khan SM; Hadi Y; Thakkar S; Singh S
    Endoscopy; 2023 Nov; 55(11):1052-1054. PubMed ID: 37883962
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
    Puig J; Blasco G; Daunis-I-Estadella J; Loshuertos E; Codina J; Cuba V; Ortiz R; Xifra G; Ricart W; Pedraza S; Federici M; Fernández-Real JM
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):180-6. PubMed ID: 25510350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The intersection of nonalcoholic fatty liver disease and obesity.
    Woo Baidal JA; Lavine JE
    Sci Transl Med; 2016 Jan; 8(323):323rv1. PubMed ID: 26819197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time to consider a holistic approach to the treatment of non-alcoholic fatty liver disease in obese young people?
    Byrne CD; Targher G
    Gut; 2023 Jul; 72(7):1238-1239. PubMed ID: 35944926
    [No Abstract]   [Full Text] [Related]  

  • 26. Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients.
    Shao C; Ye J; Li F; Lin Y; Wu T; Wang W; Feng S; Zhong B
    Dig Dis Sci; 2020 Jun; 65(6):1850-1860. PubMed ID: 31724099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Pentraxin 3 Fragment as a Noninvasive Marker of Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents.
    Hamza RT; Elfaramawy AA; Mahmoud NH
    Horm Res Paediatr; 2016; 86(1):11-20. PubMed ID: 27309736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk Stratification for Sarcopenic Obesity in Nonalcoholic Fatty Liver Disease.
    Lai R; Nguyen MH
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2984. PubMed ID: 36842631
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".
    Fang YL; Chen H; Wang CL; Liang L
    World J Gastroenterol; 2018 Jul; 24(27):2974-2983. PubMed ID: 30038464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re: Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children.
    Triebel J; Bertsch T
    Horm Metab Res; 2024 Jun; 56(6):471. PubMed ID: 38698579
    [No Abstract]   [Full Text] [Related]  

  • 31. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric Non-alcoholic Fatty Liver Disease.
    Uppal V; Mansoor S; Furuya KN
    Curr Gastroenterol Rep; 2016 May; 18(5):24. PubMed ID: 27086005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of nonalcoholic fatty liver disease using magnetic resonance in obese children and adolescents.
    Benetolo PO; Fernandes MIM; Ciampo IRLD; Elias-Junior J; Sawamura R
    J Pediatr (Rio J); 2019; 95(1):34-40. PubMed ID: 29438686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
    Chalasani N; Younossi Z; Lavine JE; Charlton M; Cusi K; Rinella M; Harrison SA; Brunt EM; Sanyal AJ
    Hepatology; 2018 Jan; 67(1):328-357. PubMed ID: 28714183
    [No Abstract]   [Full Text] [Related]  

  • 35. Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese.
    Ooi GJ; Mgaieth S; Eslick GD; Burton PR; Kemp WW; Roberts SK; Brown WA
    Obes Rev; 2018 Feb; 19(2):281-294. PubMed ID: 29119725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
    Petta S; Wai-Sun Wong V; Bugianesi E; Fracanzani AL; Cammà C; Hiriart JB; Lai-Hung Wong G; Vergniol J; Wing-Hung Chan A; Giannetti A; Merrouche W; Lik-Yuen Chan H; Le-Bail B; Lombardi R; Guastella S; Craxì A; de Ledinghen V
    Am J Gastroenterol; 2019 Jun; 114(6):916-928. PubMed ID: 31169533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
    Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
    Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis.
    Kim D; Kim W; Joo SK; Bae JM; Kim JH; Ahmed A
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):123-131.e1. PubMed ID: 28823829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.